<p>Pennant Group Inc ((PNTG)) 已召開其第一季度財報電話會議。以下是會議的主要亮點。</p>
<h3>在 TipRanks 上享受 55% 的折扣</h3>
<ul>
<li>解鎖對沖基金級別的數據和強大的投資工具，以做出更聰明、更精準的決策</li>
<li>發現表現優異的股票投資理念，並升級到市場領先者的投資組合，使用智能投資者推薦</li>
</ul>
<p>Pennant Group 最近的財報電話會議傳達了謹慎樂觀的基調，管理層強調了通過收購和家庭健康與臨終關懷的有機增長推動的強勁收入和利潤增長，同時老年生活的利潤率也在改善。然而，管理層也強調了整合成本、電子病歷過渡的干擾以及適度的流動性作為短期限制，敦促投資者預期在大型收購被吸收時會出現一些波動。</p>
<h2>強勁的收入增長和利潤改善</h2>
<p>Pennant 報告的 GAAP 收入為 2.854 億美元，同比增長 36%，主要得益於收購擴張和穩健的有機表現。GAAP 淨收入增長 9.6% 至 850 萬美元，而調整後的淨收入增長 19.8% 至 1150 萬美元，使調整後的稀釋每股收益達到 0.32 美元，比去年同期增長 18.5%。</p>
<h2>儘管整合拖累，調整後的 EBITDA 仍在攀升</h2>
<p>調整後的 EBITDA 達到 2170 萬美元，增長 32.6%，反映出整個投資組合的運營槓桿改善。在不考慮非控股權益的情況下，調整後的 EBITDA 增長 37.2% 至 2350 萬美元，顯示出儘管整合和過渡成本對錶面利潤率造成壓力，但基礎盈利能力仍在擴展。</p>
<h2>家庭健康與臨終關懷推動細分市場表現優異</h2>
<p>家庭健康與臨終關懷細分市場仍然是增長的引擎，產生收入 2.291 億美元，同比增長 43.3%。該細分市場的調整後 EBITDA 增長 33.7% 至 3360 萬美元，而在不考慮非控股權益的情況下，調整後的 EBITDA 增長 36.6% 至 3540 萬美元，突顯了護理連續體戰略的強大。</p>
<h2>家庭健康量激增，門店表現穩健</h2>
<p>家庭健康的總入院人數激增 62.7% 至 30721 人，醫療保險入院人數增長 75.1% 至 13303 人，反映出收購和強勁的需求。門店表現也健康，總入院人數增長 5.8%，同店醫療保險入院人數增長 9.2%，顯示出超出收購範圍的有機增長。</p>
<h2>臨終關懷的增長得益於良好的臨牀結果</h2>
<p>臨終關懷的平均每日住院人數同比增長 37% 至 5199 人，同店住院人數增長 10.2% 至 3952 人，突顯出廣泛的擴張。管理層指出了有利的臨牀結果，包括關鍵機構的高訪問率，並提到與擬議的 2026 年臨終關懷費率增加的對齊，為業務的進一步增長奠定了基礎。</p>
<h2>門店利潤率在整個投資組合中增強</h2>
<p>在不考慮非控股權益的情況下，同店細分市場的調整後 EBITDA 利潤率提高至 17.2%，同比增長 110 個基點。這一利潤率的擴張表明了顯著的運營槓桿和生產力提升，儘管持續的過渡活動和整合相關的噪音仍在進行。</p>
<h2>老年生活通過收購和利潤率提升實現反彈</h2>
<p>老年生活的收入達到 5630 萬美元，同比增長 12.6%，得益於包括 Lavender Lane 在內的收購，以及在季度結束後關閉的三個社區。調整後的 EBITDA 增長 30.6% 至 640 萬美元，細分市場的利潤率提高 190 個基點至 11.8%，得益於同店入住率上升至 81%，增加了 180 個基點。</p>
<h2>領導層儲備加深以支持擴展</h2>
<p>Pennant 強調了對領導力發展的投資，提到計劃在 2025 年和 2026 年進行重要的增補和晉升。公司目前擁有 55 位首席執行官和 92 位其他 C 級領導，建立了一個廣泛的管理儲備，以支持增長並在新市場中執行復雜的整合。</p>
<h2>資產負債表和現金流趨勢向好</h2>
<p>淨債務與調整後 EBITDA 的比率為 1.93 倍，反映出適度的槓桿，因為公司繼續投資於增長。運營中使用的現金顯著改善至 340 萬美元，同比改善 1780 萬美元，儘管在信貸設施下的總借款達到 1.708 億美元。</p>
<h2>整合成本對報告利潤率造成壓力</h2>
<p>儘管盈利增長強勁，家庭健康與臨終關懷的調整後 EBITDA 利潤率在不考慮非控股權益的情況下下降 70 個基點至 15.5%，這是預期之中的。管理層將壓力歸因於超過 50 個新運營的過渡和過渡服務協議下的臨時高成本，將這些視為對結構性更強平台的短期阻力。</p>
<h2>EMR 過渡和天氣影響短期運營</h2>
<p>高管們指出，由於電子病歷過渡和季節性因素（包括嚴重的 1 月天氣），運營受到干擾，這暫時對住院人數和入院人數造成壓力。在電話會議時，東南部的五個整合波次中只有兩個完全遷移，最大的波次尚未到來，增加了短期執行風險。</p>
<h2>收購驅動的老年生活入住率波動</h2>
<p>儘管同店入住率有所改善，但所有店鋪的老年生活入住率環比下降約 200 個基點，主要由於新收購的低入住率社區和假日季節性。管理層將此視為與收購相關的波動，預計隨着整合的推進，入住率和盈利能力將逐漸正常化。</p>
<h2>流動性緊張但在當前槓桿下可控</h2>
<p>Pennant 在季度末手頭有 490 萬美元現金，而未償還借款為 1.708 億美元，留下相對薄弱的現金緩衝。管理層認為，槓桿在調整後 EBITDA 的兩倍以下仍然合理，但承認持續的資本支出和整合支出在短期內收緊了靈活性。</p>
<h2>勞動力和報銷壓力仍然是關鍵風險</h2>
<p>公司繼續面臨工資通脹，特別是在臨牀崗位上，即使在推動生產力提升和人員優化的同時。與此同時，醫療保險家庭健康基礎費率降低 1.3% 限制了收入增長，迫使 Pennant 通過提高效率和嚴格控制成本來抵消報銷壓力。</p>
<h2>高額資本支出和一次性整合支出</h2>
<p>年初資本支出較高，因為 Pennant 在東南部投資於老年生活整合和基礎設施建設。管理層重申全年資本支出預期約為 1500 萬至 1800 萬美元，並指出支出是前期集中，可能在短期內造成拖累，直到收益顯現。</p>
<h2>監管審查和臨終關懷 CAP 風險</h2>
<p>公司正在密切關注臨終關懷 CAP 限制，某些州面臨特別壓力，同時承認對欺詐、浪費和濫用的監管關注加大。管理層看到廣泛執法行動帶來的潛在風險，但也認為隨着不合規運營商的退出，競爭環境的改善是一個機會。</p>
<h2>在整合不確定性下的保守指引</h2>
<p>Pennant 維持了全年指引，但表示業績正朝着範圍的上限發展，第一季度支持了雙位數的收入和 EBITDA 增長。領導層表示將在第二季度後重新評估，提到東南部整合波的持續以及逐步退出過渡服務協議的過渡，以及 2026 年臨終關懷費率提高的潛在利好。</p>
<p>Pennant 的財報電話會議描繪了一家正在進行激進但大體上執行良好的擴張公司的圖景，強勁的收入增長、上升的 EBITDA 以及關鍵細分市場的同店指標改善。投資者現在將關注管理層是否能夠在不犧牲本季度業績支撐的利潤率增長和交易量動能的情況下，順利應對 EMR 過渡、整合風險和更緊的流動性。</p>

PNTG

<p>Pennant Group Inc (PNTG) 報告了強勁的第一季度業績，收入同比增長 36%，達到 2.854 億美元，主要得益於收購和家庭健康與臨終關懷業務的有機增長。調整後的淨收入增長 19.8%，達到 1150 萬美元。然而，整合成本和電子病歷過渡的干擾在短期內構成挑戰。家庭健康與臨終關懷部門的收入激增 43.3%，而老年生活收入增長 12.6%。儘管運營受到干擾，管理層對未來增長仍持樂觀態度，強調領導力發展和改善利潤率的重點</p>

<p>Pennant Group Inc ((PNTG)) has held its Q1 earnings call. Read on for the main highlights of the call.</p>
<div class="lb-trans"><p>Pennant Group Inc ((PNTG)) 已召開其第一季度財報電話會議。以下是會議的主要亮點。</p>
</div><h3>Claim 55% Off TipRanks</h3>
<div class="lb-trans"><h3>在 TipRanks 上享受 55% 的折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖對沖基金級別的數據和強大的投資工具，以做出更聰明、更精準的決策</li>
<li>發現表現優異的股票投資理念，並升級到市場領先者的投資組合，使用智能投資者推薦</li>
</ul>
</div><p>Pennant Group’s latest earnings call struck a cautiously upbeat tone, as management highlighted strong revenue and profit growth powered by acquisitions and organic gains in Home Health &amp; Hospice, alongside improving margins in Senior Living. However, executives also underscored integration costs, EMR transition disruptions, and modest liquidity as near‑term constraints, urging investors to expect some choppiness as large acquisitions are absorbed.</p>
<div class="lb-trans"><p>Pennant Group 最近的財報電話會議傳達了謹慎樂觀的基調，管理層強調了通過收購和家庭健康與臨終關懷的有機增長推動的強勁收入和利潤增長，同時老年生活的利潤率也在改善。然而，管理層也強調了整合成本、電子病歷過渡的干擾以及適度的流動性作為短期限制，敦促投資者預期在大型收購被吸收時會出現一些波動。</p>
</div><h2>Strong top-line growth and profit improvement</h2>
<div class="lb-trans"><h2>強勁的收入增長和利潤改善</h2>
</div><p>Pennant reported GAAP revenue of $285.4 million, up 36% year over year, driven by acquisitive expansion and solid organic performance. GAAP net income rose 9.6% to $8.5 million, while adjusted net income climbed 19.8% to $11.5 million, pushing adjusted diluted EPS to $0.32, an 18.5% increase from the prior-year quarter.</p>
<div class="lb-trans"><p>Pennant 報告的 GAAP 收入為 2.854 億美元，同比增長 36%，主要得益於收購擴張和穩健的有機表現。GAAP 淨收入增長 9.6% 至 850 萬美元，而調整後的淨收入增長 19.8% 至 1150 萬美元，使調整後的稀釋每股收益達到 0.32 美元，比去年同期增長 18.5%。</p>
</div><h2>Adjusted EBITDA climbs despite integration drag</h2>
<div class="lb-trans"><h2>儘管整合拖累，調整後的 EBITDA 仍在攀升</h2>
</div><p>Adjusted EBITDA reached $21.7 million, a 32.6% jump, reflecting improved operating leverage across the portfolio. On a prior-to-noncontrolling-interest basis, adjusted EBITDA rose 37.2% to $23.5 million, showing the underlying profitability expansion even as integration and transition costs weighed on headline margins.</p>
<div class="lb-trans"><p>調整後的 EBITDA 達到 2170 萬美元，增長 32.6%，反映出整個投資組合的運營槓桿改善。在不考慮非控股權益的情況下，調整後的 EBITDA 增長 37.2% 至 2350 萬美元，顯示出儘管整合和過渡成本對錶面利潤率造成壓力，但基礎盈利能力仍在擴展。</p>
</div><h2>Home Health &amp; Hospice drives segment outperformance</h2>
<div class="lb-trans"><h2>家庭健康與臨終關懷推動細分市場表現優異</h2>
</div><p>The Home Health &amp; Hospice segment remained the engine of growth, generating revenue of $229.1 million, up 43.3% year over year. Segment adjusted EBITDA rose 33.7% to $33.6 million, and adjusted EBITDA prior to noncontrolling interest increased 36.6% to $35.4 million, underscoring the strength of the care continuum strategy.</p>
<div class="lb-trans"><p>家庭健康與臨終關懷細分市場仍然是增長的引擎，產生收入 2.291 億美元，同比增長 43.3%。該細分市場的調整後 EBITDA 增長 33.7% 至 3360 萬美元，而在不考慮非控股權益的情況下，調整後的 EBITDA 增長 36.6% 至 3540 萬美元，突顯了護理連續體戰略的強大。</p>
</div><h2>Home Health volumes surge with solid same-store gains</h2>
<div class="lb-trans"><h2>家庭健康量激增，門店表現穩健</h2>
</div><p>Total Home Health admissions surged 62.7% to 30,721, with Medicare admissions up 75.1% to 13,303, reflecting both acquisitions and robust demand. Same-store performance was also healthy, as total admissions grew 5.8% and same-store Medicare admissions rose 9.2%, signaling organic growth beyond the acquired footprint.</p>
<div class="lb-trans"><p>家庭健康的總入院人數激增 62.7% 至 30721 人，醫療保險入院人數增長 75.1% 至 13303 人，反映出收購和強勁的需求。門店表現也健康，總入院人數增長 5.8%，同店醫療保險入院人數增長 9.2%，顯示出超出收購範圍的有機增長。</p>
</div><h2>Hospice growth supported by strong clinical outcomes</h2>
<div class="lb-trans"><h2>臨終關懷的增長得益於良好的臨牀結果</h2>
</div><p>Hospice average daily census rose 37% year over year to 5,199, with same-store census climbing 10.2% to 3,952, highlighting broad-based expansion. Management pointed to favorable clinical outcomes, including high visit rates at key agencies, and noted alignment with the proposed 2026 hospice rate increase, positioning the business for further upside.</p>
<div class="lb-trans"><p>臨終關懷的平均每日住院人數同比增長 37% 至 5199 人，同店住院人數增長 10.2% 至 3952 人，突顯出廣泛的擴張。管理層指出了有利的臨牀結果，包括關鍵機構的高訪問率，並提到與擬議的 2026 年臨終關懷費率增加的對齊，為業務的進一步增長奠定了基礎。</p>
</div><h2>Same-store margins strengthen across the portfolio</h2>
<div class="lb-trans"><h2>門店利潤率在整個投資組合中增強</h2>
</div><p>Same-store segment adjusted EBITDA margin prior to noncontrolling interest improved to 17.2%, an increase of 110 basis points year over year. This margin expansion indicates meaningful operational leverage and productivity gains, achieved despite ongoing transition activity and integration-related noise.</p>
<div class="lb-trans"><p>在不考慮非控股權益的情況下，同店細分市場的調整後 EBITDA 利潤率提高至 17.2%，同比增長 110 個基點。這一利潤率的擴張表明了顯著的運營槓桿和生產力提升，儘管持續的過渡活動和整合相關的噪音仍在進行。</p>
</div><h2>Senior Living rebounds with acquisitions and margin gains</h2>
<div class="lb-trans"><h2>老年生活通過收購和利潤率提升實現反彈</h2>
</div><p>Senior Living revenue reached $56.3 million, up 12.6%, supported by acquisitions including Lavender Lane and three communities closed after quarter end. Adjusted EBITDA rose 30.6% to $6.4 million, and segment margins improved 190 basis points to 11.8%, aided by rising same-store occupancy of 81%, up 180 basis points.</p>
<div class="lb-trans"><p>老年生活的收入達到 5630 萬美元，同比增長 12.6%，得益於包括 Lavender Lane 在內的收購，以及在季度結束後關閉的三個社區。調整後的 EBITDA 增長 30.6% 至 640 萬美元，細分市場的利潤率提高 190 個基點至 11.8%，得益於同店入住率上升至 81%，增加了 180 個基點。</p>
</div><h2>Leadership bench deepens to support scaling</h2>
<div class="lb-trans"><h2>領導層儲備加深以支持擴展</h2>
</div><p>Pennant emphasized investments in leadership development, citing significant additions and promotions planned through 2025 and 2026. The company now counts 55 CEOs and 92 other C‑level leaders in operations, establishing a broad management bench designed to sustain growth and execute complex integrations across new markets.</p>
<div class="lb-trans"><p>Pennant 強調了對領導力發展的投資，提到計劃在 2025 年和 2026 年進行重要的增補和晉升。公司目前擁有 55 位首席執行官和 92 位其他 C 級領導，建立了一個廣泛的管理儲備，以支持增長並在新市場中執行復雜的整合。</p>
</div><h2>Balance sheet and cash flow trend in the right direction</h2>
<div class="lb-trans"><h2>資產負債表和現金流趨勢向好</h2>
</div><p>Net debt to adjusted EBITDA stood at 1.93 times, reflecting moderate leverage as the company continues to invest in growth. Cash used in operations improved significantly to $3.4 million, a $17.8 million year-over-year improvement, even as total borrowings under the credit facility reached $170.8 million.</p>
<div class="lb-trans"><p>淨債務與調整後 EBITDA 的比率為 1.93 倍，反映出適度的槓桿，因為公司繼續投資於增長。運營中使用的現金顯著改善至 340 萬美元，同比改善 1780 萬美元，儘管在信貸設施下的總借款達到 1.708 億美元。</p>
</div><h2>Integration costs weigh on reported margins</h2>
<div class="lb-trans"><h2>整合成本對報告利潤率造成壓力</h2>
</div><p>Despite robust earnings growth, Home Health &amp; Hospice adjusted EBITDA margin prior to noncontrolling interest slipped 70 basis points to 15.5%, as expected. Management attributed the pressure to the transition of more than 50 new operations and temporary higher costs under a transition services agreement, framing these as short-term headwinds to a structurally stronger platform.</p>
<div class="lb-trans"><p>儘管盈利增長強勁，家庭健康與臨終關懷的調整後 EBITDA 利潤率在不考慮非控股權益的情況下下降 70 個基點至 15.5%，這是預期之中的。管理層將壓力歸因於超過 50 個新運營的過渡和過渡服務協議下的臨時高成本，將這些視為對結構性更強平台的短期阻力。</p>
</div><h2>EMR transitions and weather disrupt near-term operations</h2>
<div class="lb-trans"><h2>EMR 過渡和天氣影響短期運營</h2>
</div><p>Executives flagged operational disruption from electronic medical record transitions and seasonal factors, including severe January weather, which temporarily pressured census and admissions. At the time of the call, only two of five integration waves in the Southeast were fully migrated, with the largest waves ahead, heightening near-term execution risk.</p>
<div class="lb-trans"><p>高管們指出，由於電子病歷過渡和季節性因素（包括嚴重的 1 月天氣），運營受到干擾，這暫時對住院人數和入院人數造成壓力。在電話會議時，東南部的五個整合波次中只有兩個完全遷移，最大的波次尚未到來，增加了短期執行風險。</p>
</div><h2>Acquisition-driven occupancy volatility in Senior Living</h2>
<div class="lb-trans"><h2>收購驅動的老年生活入住率波動</h2>
</div><p>While same-store occupancy improved, all-store Senior Living occupancy declined about 200 basis points sequentially, largely due to newly acquired, low-occupancy communities and holiday seasonality. Management framed this as acquisition-related lumpiness, with expectations that occupancy and profitability will gradually normalize as integration progresses.</p>
<div class="lb-trans"><p>儘管同店入住率有所改善，但所有店鋪的老年生活入住率環比下降約 200 個基點，主要由於新收購的低入住率社區和假日季節性。管理層將此視為與收購相關的波動，預計隨着整合的推進，入住率和盈利能力將逐漸正常化。</p>
</div><h2>Liquidity tight but manageable under current leverage</h2>
<div class="lb-trans"><h2>流動性緊張但在當前槓桿下可控</h2>
</div><p>Pennant ended the quarter with $4.9 million of cash on hand against $170.8 million of outstanding borrowings, leaving a relatively thin cash cushion. Management argued that leverage remains reasonable at under two times adjusted EBITDA, but acknowledged that ongoing capex and integration spending tighten flexibility in the near term.</p>
<div class="lb-trans"><p>Pennant 在季度末手頭有 490 萬美元現金，而未償還借款為 1.708 億美元，留下相對薄弱的現金緩衝。管理層認為，槓桿在調整後 EBITDA 的兩倍以下仍然合理，但承認持續的資本支出和整合支出在短期內收緊了靈活性。</p>
</div><h2>Labor and reimbursement pressure remain key risks</h2>
<div class="lb-trans"><h2>勞動力和報銷壓力仍然是關鍵風險</h2>
</div><p>The company continues to face wage inflation, particularly in clinical roles, even as it pushes for productivity gains and staffing optimization. At the same time, a 1.3% reduction in the Medicare Home Health base rate constrains top-line growth, forcing Pennant to offset reimbursement pressure with efficiency improvements and disciplined cost control.</p>
<div class="lb-trans"><p>公司繼續面臨工資通脹，特別是在臨牀崗位上，即使在推動生產力提升和人員優化的同時。與此同時，醫療保險家庭健康基礎費率降低 1.3% 限制了收入增長，迫使 Pennant 通過提高效率和嚴格控制成本來抵消報銷壓力。</p>
</div><h2>Elevated capex and one-time integration spending</h2>
<div class="lb-trans"><h2>高額資本支出和一次性整合支出</h2>
</div><p>Capital expenditures are elevated early in the year as Pennant invests in Senior Living integrations and infrastructure buildout in the Southeast. Management reiterated full-year capex expectations of roughly $15 million to $18 million, noting that spending is front-loaded and could present a near-term drag before benefits accrue.</p>
<div class="lb-trans"><p>年初資本支出較高，因為 Pennant 在東南部投資於老年生活整合和基礎設施建設。管理層重申全年資本支出預期約為 1500 萬至 1800 萬美元，並指出支出是前期集中，可能在短期內造成拖累，直到收益顯現。</p>
</div><h2>Regulatory scrutiny and hospice CAP exposure</h2>
<div class="lb-trans"><h2>監管審查和臨終關懷 CAP 風險</h2>
</div><p>The company is closely monitoring hospice CAP constraints, with particular pressure in certain states, while acknowledging heightened regulatory focus on fraud, waste, and abuse. Management sees potential risk from broad enforcement actions but also views a cleaner competitive landscape as an opportunity as noncompliant operators exit.</p>
<div class="lb-trans"><p>公司正在密切關注臨終關懷 CAP 限制，某些州面臨特別壓力，同時承認對欺詐、浪費和濫用的監管關注加大。管理層看到廣泛執法行動帶來的潛在風險，但也認為隨着不合規運營商的退出，競爭環境的改善是一個機會。</p>
</div><h2>Conservative guidance amid integration uncertainty</h2>
<div class="lb-trans"><h2>在整合不確定性下的保守指引</h2>
</div><p>Pennant maintained its full-year guidance but indicated performance is tracking toward the upper end of the range, supported by double-digit revenue and EBITDA growth in the first quarter. Leadership signaled it will reassess after the second quarter, citing ongoing Southeast integration waves and a staged transition off the transition services agreement, as well as potential tailwinds from the proposed 2026 hospice rate increase.</p>
<div class="lb-trans"><p>Pennant 維持了全年指引，但表示業績正朝着範圍的上限發展，第一季度支持了雙位數的收入和 EBITDA 增長。領導層表示將在第二季度後重新評估，提到東南部整合波的持續以及逐步退出過渡服務協議的過渡，以及 2026 年臨終關懷費率提高的潛在利好。</p>
</div><p>Pennant’s earnings call painted a picture of a company in the midst of an aggressive but largely well-executed expansion, with strong revenue growth, rising EBITDA, and improving same-store metrics across key segments. Investors will now watch whether management can navigate EMR transitions, integration risk, and tighter liquidity without sacrificing the margin gains and volume momentum that underpinned this quarter’s performance.</p>
<div class="lb-trans"><p>Pennant 的財報電話會議描繪了一家正在進行激進但大體上執行良好的擴張公司的圖景，強勁的收入增長、上升的 EBITDA 以及關鍵細分市場的同店指標改善。投資者現在將關注管理層是否能夠在不犧牲本季度業績支撐的利潤率增長和交易量動能的情況下，順利應對 EMR 過渡、整合風險和更緊的流動性。</p>
</div>

Pennant Group 在快速增長的同時平衡整合風險